aibioNasdaq files Form 25 to delist Avenue Therapeutics common stock
Tickers ATXI
The Nasdaq Stock Market LLC filed a Form 25-NSE on July 18, 2025, to remove Avenue Therapeutics common stock from listing and registration.
Key facts
- Company
- Avenue Therapeutics, Inc. (OTC: ATXI)
- News type
- Listings
- Primary source
- Avenue Therapeutics, Inc. 25-NSE (2025-07-18)
The Nasdaq Stock Market LLC filed a Form 25-NSE with the Securities and Exchange Commission on 2025-07-18 to remove the common stock of Avenue Therapeutics, Inc. from listing and registration on the exchange.
A Form 25 is the notice an exchange files with the SEC when a class of securities is removed from listing and registration. Nasdaq filed this one under 17 CFR 240.12d2-2(b), the provision an exchange cites when it removes a security under its own rules.
The notice was filed for Nasdaq by a member of its hearings staff, whose title is listed as Hearings Advisor. It identifies the company as Avenue Therapeutics, Inc., at 2 Gansevoort Street, 9th Floor, New York, with Commission file number 333-217552. The only class of securities named in the form is the company's common stock.
The form is a short exchange notice. Readers can see the original on the SEC website.